The 3-year survival rate of intrahepatic cholangiocellular carcinoma after effective surgical treatment is 16%~61%, and the 5-year survival rate is 24%~44%. Intrahepatic cholangiocellular carcinoma is a kind of tumor with a very high degree of malignancy, and its survival rate is very low. After effective surgical treatment, the 3-year survival rate is also very low, which is only 16%~61%. It is mainly because the probability of early detection of intrahepatic cholangiocellular carcinoma is low, because there is no typical symptom in the early stage, so the discovery belongs to the middle and late stage, at this time, the treatment effect is poor and the survival time is short. The most common symptoms of intrahepatic cholangiocellular carcinoma are right upper abdominal pain and weight loss, and jaundice occurs in about 25% of patients. If patients have any discomfort, they should seek medical treatment promptly and take reasonable treatment under doctors’ guidance. Surgery is the first choice of treatment to prolong the survival period of intrahepatic cholangiocellular carcinoma.